Program
ledaborbactam etzadroxil
Also written as “VNRX-7145” and “Ledaborbactam etzadroxil”.
Its studies are led by Basilea Pharmaceutica.
Furthest: phase 1, since Jan 14, 20205 company-led studies, 1 open or runningNext primary completion: Dec 30, 2026 (phase 1)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Basilea Pharmaceutica | 51 open or running | phase 1since Jan 14, 2020 | Jan 14, 2020 | Dec 30, 2026phase 1 · NCT06733675 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jan 14, 2020First study: phase 1 study in Healthy VolunteersFirst studyNCT04243863 · 83 enrolled · United States
- May 3, 2021Phase 1 study in Healthy SubjectsNCT04877379 · 53 enrolled · Netherlands
- Aug 3, 2022Phase 1 study in PharmacokineticsNCT05488678 · 32 enrolled · United States
- Sep 1, 2022Phase 1 study in PharmacokineticsNCT05527834 · 24 enrolled · United States
- Dec 10, 2024Phase 1 study in Healthy VolunteerNCT06733675 · 96 planned · United States
Ahead
- Dec 30, 2026Primary completion: phase 1 study in Healthy VolunteerNCT06733675
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 5 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06733675Healthy Volunteer · United States | 1 | Recruiting | Dec 30, 2026 | 96 |
| NCT05527834Pharmacokinetics · United States | 1 | Completed | Feb 6, 2023 | 24 |
| NCT05488678Pharmacokinetics · United States | 1 | Completed | Nov 23, 2023 | 32 |
| NCT04877379Healthy Subjects · Netherlands | 1 | Completed | Nov 10, 2021 | 53 |
| NCT04243863Healthy Volunteers · United States | 1 | Completed | Apr 5, 2021 | 83 |
How it is read
Names in the registry
- “VNRX-7145”, 4 entries
- “Ledaborbactam etzadroxil”, 1 entry
Conditions, from the studies’ own filings
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.